VolitionRx Limited (VNRX)
VNRX Stock Price Chart
Explore VolitionRx Limited interactive price chart. Choose custom timeframes to analyze VNRX price movements and trends.
VNRX Company Profile
Discover essential business fundamentals and corporate details for VolitionRx Limited (VNRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
2 Mar 2012
Employees
85.00
Website
https://www.volition.comCEO
Cameron Reynolds MBA
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
VNRX Financial Timeline
Browse a chronological timeline of VolitionRx Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.04, while revenue estimate is $715.59K.
Earnings released on 14 Aug 2025
EPS came in at -$0.06 falling short of the estimated -$0.05 by -20.00%, while revenue for the quarter reached $406.69K , missing expectations by -53.84%.
Earnings released on 15 May 2025
EPS came in at -$0.06 matching the estimated -$0.06, while revenue for the quarter reached $246.39K , missing expectations by -77.27%.
Earnings released on 31 Mar 2025
EPS came in at -$0.06 matching the estimated -$0.06, while revenue for the quarter reached $191.66K , missing expectations by -64.86%.
Earnings released on 14 Nov 2024
EPS came in at -$0.07 matching the estimated -$0.07, while revenue for the quarter reached $474.52K , missing expectations by -12.99%.
Earnings released on 14 Aug 2024
EPS came in at -$0.08 surpassing the estimated -$0.09 by +11.11%, while revenue for the quarter reached $395.80K , missing expectations by -17.54%.
Earnings released on 13 May 2024
EPS came in at -$0.10 surpassing the estimated -$0.11 by +9.09%, while revenue for the quarter reached $171.54K , missing expectations by -56.02%.
Earnings released on 25 Mar 2024
EPS came in at -$0.11 matching the estimated -$0.11, while revenue for the quarter reached $243.97K , missing expectations by -45.78%.
Earnings released on 14 Nov 2023
EPS came in at -$0.11 surpassing the estimated -$0.12 by +8.33%, while revenue for the quarter reached $165.21K , missing expectations by -63.29%.
Earnings released on 14 Aug 2023
EPS came in at -$0.14 falling short of the estimated -$0.13 by -7.69%, while revenue for the quarter reached $216.31K , missing expectations by -19.89%.
Earnings released on 10 May 2023
EPS came in at -$0.15 falling short of the estimated -$0.14 by -7.14%, while revenue for the quarter reached $149.81K , missing expectations by -64.33%.
Earnings released on 15 Mar 2023
EPS came in at -$0.13 surpassing the estimated -$0.15 by +13.33%, while revenue for the quarter reached $119.72K , missing expectations by -45.58%.
Earnings released on 14 Nov 2022
EPS came in at -$0.14 surpassing the estimated -$0.15 by +6.67%, while revenue for the quarter reached $32.71K , missing expectations by -65.32%.
Earnings released on 10 Aug 2022
EPS came in at -$0.14 surpassing the estimated -$0.15 by +6.67%, while revenue for the quarter reached $39.75K , missing expectations by -64.11%.
Earnings released on 11 May 2022
EPS came in at -$0.14 falling short of the estimated -$0.01 by -900.00%, while revenue for the quarter reached $114.21K , missing expectations by -98.86%.
Earnings released on 30 Mar 2022
EPS came in at -$0.15 falling short of the estimated -$0.14 by -7.14%, while revenue for the quarter reached $14.24K , missing expectations by -12.21%.
Earnings released on 10 Nov 2021
EPS came in at -$0.13 falling short of the estimated -$0.10 by -30.00%, while revenue for the quarter reached $25.48K , beating expectations by +42.86%.
Earnings released on 11 Aug 2021
EPS came in at -$0.10 surpassing the estimated -$0.12 by +16.67%, while revenue for the quarter reached $24.78K , missing expectations by -0.87%.
Earnings released on 11 May 2021
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $25.53K , meeting expectations.
Earnings released on 22 Mar 2021
EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%, while revenue for the quarter reached $7.12K .
Earnings released on 12 Nov 2020
EPS came in at -$0.09 surpassing the estimated -$0.11 by +18.18%, while revenue for the quarter reached $575.00 , missing expectations by -15.32%.
VNRX Stock Performance
Access detailed VNRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.